A detailed history of Partners In Financial Planning transactions in Abbott Laboratories stock. As of the latest transaction made, Partners In Financial Planning holds 2,799 shares of ABT stock, worth $363,953. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,799
Previous 3,145 11.0%
Holding current value
$363,953
Previous $428 Million 12.36%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$120.51 - $136.62 $41,696 - $47,270
-346 Reduced 11.0%
2,799 $375 Million
Q1 2025

Apr 30, 2025

BUY
$111.1 - $140.22 $95,212 - $120,168
857 Added 37.46%
3,145 $417 Million
Q4 2024

Feb 12, 2025

BUY
$111.93 - $119.39 $256,095 - $273,164
2,288 New
2,288 $259 Million
Q3 2024

Feb 26, 2025

BUY
$100.07 - $118.13 $8,806 - $10,395
88 Added 4.0%
2,288 $261 Million
Q4 2023

Feb 26, 2025

SELL
$90.19 - $110.4 $7,936 - $9,715
-88 Reduced 3.85%
2,200 $242 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Partners In Financial Planning Portfolio

Follow Partners In Financial Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners In Financial Planning, based on Form 13F filings with the SEC.

News

Stay updated on Partners In Financial Planning with notifications on news.